abstract |
The present invention relates to a sustained release formulation that is intended to release zolpidem or its salts for a predetermined time by a biphasic dissolution profile, wherein the first phase is an immediate release phase and the second phase is a delayed release phase. While certain embodiments are designed to prevent abuse. |